目次
Chembiomolecular chemistry Chemistry of mycolactones, the causative toxins of Buruli ulcer
Practical synthesis of Tamiflu and beyond
An approach toward indentification of target proteins of maitotoxin based on organic synthesis
Inhibitors of fatty acid amide hidrolase
Small molecule tools for cell biology and cell therapy
Toward the discovery of small molecules affecting RNA function
New insights from a focused library approach aiming at development of inhibitors of dual-specificity protein phosphatases
The deep oceans as a source for new treatments for cancer
Search for new medicinal seeds from marine organisms
Identification of protein-small molecule interactions by chemical array
Chembiomolecular biology Small molecule-induced proximity
High-throughput screening for small molecule modulators of FGFR2-Ⅲb pre-mRNA splicing
Identification of signaling pathways that mediate dietary restriction-induced longevity in caenorhabditis elegans
Roles for the stress-responsive kinases ASK1 and ASK2 in tumorigenesis
Tailored synthetic surfaces to control human pluripotent stem cell self-renewal
Cell-surface glycoconjugates controlling human T-lymphocyte homing
Establishment of novel system for studying the Syk function in B cells
Visual screening for the natural compounds that affect the formation of nuclear structures
Versatile orphan nuclear recepter NR4A2 as a promising molecular target for multiple sclerosis and other autoimmune diseases
Antiviral microRNA
Synaptic function monitored using chemobiomolecular indicators
Chembiomolecular medicinal chemistry Practical catalytic asymmetric synthesis of a promising drug candidate
Hunting the targets of natural product-inspired compounds
Chemical approaches for understanding and controlling infectious diseases
Nongenomic mechanism-mediated renal fibrosis-decreasing activity of a series of PPAR-γ agonists
Novel carbohydrate-based inhibitors that target influenza A virus sialidase
Multidrug efflux pumps and development of therapeutic strategies to control infectious diseases
Enzymes as chemotherapeutic agents
Mechanism of action of new antiinfectious agents from microorganisms
Correction of RNA splicing with antisense oligonucleotides as a therapeutic strategy for a neurodegenerative disease
Modulation of pre-mRNA splicing patterns with synthetic chemicals and their clinical applications
